Nektar Therapeutics (NKTR) vs First Tracks Biotherapeutics Inc (TRAX)

A side-by-side comparison of Nektar Therapeutics and First Tracks Biotherapeutics Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Nektar Therapeutics logo
NKTR
Nektar Therapeutics
$1.14B
$39.74HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT
First Tracks Biotherapeutics Inc logo
TRAX
First Tracks Biotherapeutics Inc
$1.11B
$31.76HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT

Total return — NKTR vs TRAX

growth of $100 · dividends reinvested · last 1y
NKTR -41.3% (-41.3%/yr)TRAX +73.6% (+73.6%/yr)TRAX compounded faster over this window
50100150200250Start $100$59$174
NKTR TRAX

NKTR vs TRAX: by the numbers

  • •NKTR is the larger company ($1.14B vs $1.11B market cap).
  • •Both run net losses; TRAX's is the smaller (0.00% vs -287.84% net margin).

Metrics side by side

Valuation

MetricNKTRTRAX
P/S ratio20.88N/A
P/B ratio1.266.57

Profitability

MetricNKTRTRAX
Gross margin99.36%0.00%
Operating margin-240.38%0.00%
Net margin-287.84%0.00%
ROE-17.40%-57.77%
ROIC-12.53%-59.76%

Growth (annualized)

MetricNKTRTRAX
Revenue CAGR (5Y)-12.34%N/A
Total return CAGR (5Y)-30.33%N/A

Go deeper

Full NKTR analysisFull TRAX analysisInteractive comparison tool

Dig into the metrics

Nektar Therapeutics ROEFirst Tracks Biotherapeutics ROENektar Therapeutics operating marginFirst Tracks Biotherapeutics operating marginNektar Therapeutics revenue growthFirst Tracks Biotherapeutics revenue growthNektar Therapeutics free cash flowFirst Tracks Biotherapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.